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The zinc finger transcription factor GLI3 is considered a repressor of vertebrate Hedgehog (Hh) signaling. In humans, the
absence of GLI3 function causes Greig cephalopolysyndactyly syndrome, affecting the development of the brain, eye, face,
and limb. Because the etiology of these malformations is not well understood, we examined the phenotype of mouse Gli3/
mutants as a model to investigate this. We observed an up-regulation of Fgf8 in the anterior neural ridge, isthmus, eye, facial
primordia, and limb buds of mutant embryos, sites coinciding with the human disease. Intriguingly, endogenous apoptosis
was reduced in Fgf8-positive areas in Gli3/ mutants. Since SHH is thought to be involved in Fgf8 regulation, we compared
Fgf8 expression in Shh/ and Gli3/;Shh/ mutant embryos. Whereas Fgf8 expression was almost absent in Shh/
mutants, it was up-regulated in Gli3/;Shh/ double mutants, suggesting that SHH is not required for Fgf8 induction, and
that GLI3 normally represses Fgf8 independently of SHH. In the limb bud, we provide evidence that ectopic expression of
Gremlin in Gli3/ mutants might contribute to a decrease in apoptosis. Together, our data reveal that GLI3 limits
Fgf8-expression domains in multiple tissues, through a mechanism that may include the induction or maintenance of
apoptosis. © 2002 Elsevier Science (USA)
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The Hedgehog (Hh) signaling cascade is essential for
many aspects of mammalian embryogenesis, including neu-
ral tube, face, limb, hair, tooth, and gut development
(Chiang et al., 1996). Much remains to be learned about the
signaling cascade in both Drosophila, in which pioneering
work has been done, and vertebrates (Ingham and McMa-
hon, 2001). In Drosophila, Hh acts as a secreted signaling
protein that inhibits the transmembrane receptor Patched
(Ptc) (Ingham, 1998). In the absence of Hh, Ptc inhibits the
activity of a second transmembrane protein, Smoothened
(Smo), thereby blocking the downstream signaling cascade.
Hh binding inactivates Ptc, releasing Smo to activate down-
stream genes. Smo appears to affect a cytoplasmic protein
1 To whom correspondence should be addressed. Fax: 81-48-
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320complex that includes the zinc finger transcription factor
Cubitus interruptus (Ci) (Methot and Basler, 2001). Smo
activity leads to the formation of Ci as a transcriptional
activator. When Hh is absent and Ptc prevails over Smo, Ci
is proteolytically processed into a transcriptional repressor
form. Vertebrate homologs of Hh (Desert hedgehog, Indian
hedgehog, and Sonic hedgehog), Ptc (Ptc1 and 2), Smo, and
Ci (Gli1, 2, and 3) have been identified and seem to act in a
signaling cascade similar to that characterized in Drosoph-
ila. Numerous functions of the vertebrate Hedgehog signals
have been identified, in a multitude of tissues.
The Gli zinc finger proteins seem to play a central role in
the mediation and interpretation of Hedgehog signaling
(Aza-Blanc et al., 2000; Ruiz i Altaba, 1999). In mice, three
GLI transcription factors (GLI1, GLI2, and GLI3) may pos-
sess distinct yet overlapping functions in Hh signaling, as
determined by mutant analysis studies. A mutation in the
human Gli3 gene is responsible for Greig cephalopolysyn-
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dactyly syndrome (GCPS), an autosomal dominant disorder
causing mild mental retardation, hypertelorism, strabis-
mus, and polysyndactyly. The mouse Gli3/ mutant extra-
toes (XtJ) shows severe excencephaly, hypertelorism, cleft
palate, eye malformation, bone malformation, and polysyn-
dactyly (Johnson, 1967), making it a good model for study-
ing GCPS. In the brain, the dorsal telencephalon is missing,
resulting in a severe reduction of the cortex, olfactory bulb,
and hippocampus (Theil et al., 1999; Tole et al., 2000).
Although no obvious defect has been detected in the Gli3/
spinal cord, GLI3 appears to be a major repressor of the
development of ventral cell types (Litingtung and Chiang,
2000). In the spinal cord of Shh/ mutants, all ventral cell
types are missing. In contrast, in Gli3/;Shh/ double
mutants, motor neurons, V1, and V2 progenitors are able to
develop, suggesting that SHH is only required for floor plate
and V3 interneuron induction when GLI3 is missing. GLI3
therefore appears to be a major repressor of the development
of motor neurons, V1, and V2 progenitors in wild type mice.
In the limb bud, a mechanism underlying the Gli3/
mutant polydactyly phenotype involving SHH has been
postulated. Normally, Shh is expressed in zone of polarizing
activity (ZPA) to organize anterior–posterior patterning
during limb development. In the Gli3/ mutant limb bud,
ectopic Shh expression is detected on the anterior side,
opposite to the ZPA (Masuya et al., 1995). This ectopic SHH
is thought to induce the mirror image duplication of the
limb in Gli3/ embryos, suggesting that GLI3 normally
acts as a suppressor of Shh expression in the anterior part of
the limb bud (Masuya et al., 1995). However, the other
abnormalities observed in Gli3/ mutants, such as the
absence of the dorsal forebrain, excencephaly, eye dysplasia,
hypertelorism, and syndactyly, cannot be explained by this
mechanism, since no other ectopic and/or expanded Shh
expression domains are detected in Gli3/ mutants. There-
fore, we hypothesize that GLI3 has functions required for
organogenesis that are independent of SHH signaling. We
chose to investigate the expression of Fgf8 in the abnormal
tissues of Gli3/ mutants, since FGF8 is also critical for the
FIG. 1. Expanded ganglionic eminence and prosomere 3 (P3)
region in Gli3/ embryos. (A–E) Expression of Gli3 mRNA in wild
type embryos. (A, B) 8.0 and 8.5 dpc embryos, viewed from the
dorsal surface. Gli3 is expressed in the dorsal side of the head fold
and neural crest region (arrow in A, B). (C) After neural tube
closure, Gli3 is expressed in the dorsal neural tube, strongly in the
head (9.0 dpc embryo viewed from the lateral surface). (D–M) Brain
at 10.5 and 11.5 dpc; mesenchymal cells and surface ectoderm have
been removed; rostral is to the left. (D, E) Gli3 mRNA is detected
in the eye (arrowhead), hypothalamus (HT; arrows), dorsal telen-
cephalon (Te), diencephalon (Di), midbrain (MB), and hindbrain
(HB). (F, G) Pax6 mRNA distribution in the wild type (F) and
Gli3/ (G) brain at 11.5 dpc. (F) Pax6 is expressed in the dorsal
telencephalon (black arrow), P3 region (ventral thalamus; red
arrowheads), and dorsal part of P1 region (pretectum) of the
diencephalon. (G) In Gli3/ embryos, Pax6 expression in the dorsal
-
telencephalon is shifted toward the dorsal side (black arrow indi-
cates the ventral edge of Pax6 expression). Pax6 expression in the
P3 region is also expanded (red arrows in G). (H, I) Dlx2 expression
in the wild type (H) and Gli3/ (I) embryo at 11.5 dpc. Dlx2 is
detected in the ganglionic eminence (black arrow) and P3 region
(red arrowheads) in the wild type. (I) In Gli3 mutants, Dlx2 is
expanded toward the dorsal side in the ganglionic eminence (black
arrow indicates the position of dorsal edge of Dlx2 expression).
Dlx2 expression in P3 region is also expanded (red arrows). (K)
Expression of Nkx2.1 in the ganglionic eminence is expanded
dorsally (black arrow), while no change is seen in the hypothala-
mus. (L, M) Expression of Shh mRNA in the ventral midline of wild
type (L) and Gli3/ (M) brains at 11.5 dpc from the lateral view. (M)
Shh (a ventral marker) is not affected in the ventral midline in Gli3
mutants. Zli, zona limitans intrathalamica. Scale bars, 0.5 mm in
(A–M).
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developmental patterning of the affected tissues. We found
a marked up-regulation of Fgf8 expression in the brain, eye,
face, and limb buds in Gli3/ mutants. We also found that
programmed cell death was obviously reduced in these
same Fgf8-expressing sites. Our observations suggest novel
GLI3 functions in the control of Fgf8 expression and apo-
FIG. 2. Expansion of Fgf8 expression in the Gli3/ mutant brain. (A, C) Fgf8 is expressed in the anterior neural ridge (sequence bracket)
and isthmus (red arrows) at 8.5 dpc (A, frontal view; C, lateral view). (B, D) The Fgf8 domain becomes wider in Gli3/ mutants. Black arrow
indicates the position of the posterior edge of Fgf8 expression in the ANR in (A–D), and red arrows indicate anterior and posterior edge of
Fgf8 expression in the isthmus in (C–J). (E–H) After neural tube closure (9.5 dpc), Fgf8 continues to be up-regulated in the ANR (red
arrowheads) and isthmus (red arrows) in mutant embryos (E and F, lateral view; G and H, dorsal view). (I–N) Brain at 10.5 and 11.5 dpc after
removal of mesenchymal cells and surface ectoderm. (I–L) All Fgf8-expression domains are expanded in the Gli3/ mutant brain (ANR, red
arrowheads; diencephalic region, yellow arrow; isthmus, red arrows) (I and J, lateral view; K and L, frontal view). Dlx2 mRNA distribution
in the wild type (M) and Gli3/ brain (N) at 11.5 dpc, frontal view. (N) Dlx2 expression is shifted dorsally in the mutant ganglionic
eminence. (O, P) Tyrosine hydroxylase (TH) expression in wild type (O) and Gli3/ (P) mutant brains at 12.5 dpc viewed from lateral side.
TH-positive cells are detected in the diencephalon and around the isthmus (red arrowheads in O). The position of the isthmus is indicated
by a red arrow. In the Gli3/ brain, there is an increase in TH-positive neurons in the diencephalon and around the isthmus. (Q, R) Pax6
and En2 mRNA localization in wild type (Q) and Gli3/ (R) mutant brains at 10.5 dpc for determination of changes in brain region size.
Asterisks mark the boundary of each brain region for measurement (double-headed red arrow indicates diencephalic region defined by Pax6
expression, double-headed yellow arrow indicates the isthmus marked by En2 expression). (S) Schematic of brain regions measured. Graph
of brain region proportions in wild type versus Gli3/ mutants. There was a significant increase (*, P  0.05) in size of the diencephalon
(Die), posterior midbrain (pMB), and anterior hindbrain (aHB). There was a significant reduction (*, P  0.05) in size of the telencephalon
(Tel) and anterior midbrain (aMB). Scale bars, 1 mm in (A–N, Q, R); 5 mm in (O, P).
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ptosis in the developing neural tube, face, and limb, which
is most likely independent of the SHH signaling cascade.
MATERIALS AND METHODS
Mice
Gli3/ and Shh/ mutant mice were obtained from The Jackson
Laboratory (Bar Harbor, ME). Gli3 mutant mice contain the XtJ-
specific fusion transcript generated by a deletion including all 3
sequences of the Gli3 locus. In Shh mutant mice, exon 2 is deleted
by gene targeting (St-Jacques et al., 1998). Gli3/, Shh/, and
Gli3/;Shh/ mice were maintained in a mixed 129 and CD1
background. The generation and genotyping of mutant embryos
were performed as described (Mo et al., 1997; St-Jacques et al.,
1998, Maynard et al., 2002). The stage of wild type and mutant
embryos was determined by number of somite.
Whole-Mount in Situ Hybridization and
Immunohistochemistry
Whole-mount in situ hybridization was performed as described
(Motoyama et al., 1998). The cDNA fragments were isolated by
RT-PCR for use as templates in DIG-labeling in vitro transcription
reactions, according to previous reports: Dlx2 (Porteus et al., 1991),
En2 (Millen et al., 1994), Fgf8 (Tanaka et al., 1992), Gli3 (Hui and
Joyner, 1993), Gremlin (Lu et al., 2001), Nkx2.1 (Shimamura et al.,
1995), Pax2 (Dressler et al., 1990), Pax6 (Walther and Gruss, 1991),
Pax7 (Mansouri et al., 1996), Pax9 (Neubu¨ser et al., 1995), and Shh
(Echelard et al., 1993). Embryos were photographed under a dissect-
ing microscope.
The comparison of each brain region was done by measuring the
distance between each region in brains on which Pax6-En2 whole-
mount in situ hybridization had been performed (10.5 dpc, n  6 in
each group). The proportion occupied by each brain region was
determined as a percentage of the distance between the nose and
the isthmus of the corresponding brain. Differences between wild
type and Gli3/ mutant brains were analyzed by Student’s t test to
determine the level of significance. The number of the Fgf8-
expressing cells in the facial primordia and limb AER was deter-
mined by counting Fgf8-positive cells on photomicrographs of at
least six wild type and Gli3/ mutant embryos. Coronal and
transverse sections were prepared for the facial primordia and AER,
respectively. After in situ hybridization, four middle sections were
chosen for counting, and the average per section was determined.
Differences between wild type and Gli3/ mutants were analyzed
by Student’s t test to determine the level of significance. To
examine the phenotype of the neural tube and eye, some embryos
were processed after removal of the facial epithelium and mesen-
chyme surrounding the neural tube. For in situ hybridization, we
used Gli3/ embryos without the excencephaly phenotype, since
the morphology of the neural tube of exencephalic embryos is quite
different from that of wild type. Gli3/ embryos with normal
neural tube closure comprised 40% of total homozygous embryos.
Immunodetection for tyrosine hydroxylase was done by using a
rabbit anti-rat antibody (Chemicon International) as described
(Ding et al., 1998).
Apoptosis
Cell death was determined by TUNEL analysis. Wild type and
mutant embryos were dissected at 8.5, 9.5, and 11.5 dpc and fixed
with 4% paraformaldehyde in PBS. Whole-mount TUNEL reac-
tions were performed according to the procedure provided (Inter-
gen, Purchase, NY).
RESULTS
Brain Abnormalities in Gli3/ Mutants
Gli3 was expressed in the dorsal edge of the neural plate
in 8.0- to 8.5-dpc embryos (Figs. 1A and 1B). After neural
tube closure, expression was restricted to the dorsal side of
the neural tube, especially in the forebrain (Figs. 1C and
1D). In addition, Gli3 was detected in the ventral forebrain
within the hypothalamus, as well as in the eye from 10.5
dpc onwards (Figs. 1D and 1E).
Excencephaly or a reduced dorsal telencephalon has pre-
viously been reported in the Gli3/ brain (Johnson, 1967;
Theil et al., 1999). We found similar defects in dorsal–
ventral patterning in the Gli3/ mutant brain. To define
these defects, we performed marker gene analysis. In the
wild type brain at 11.5 dpc, Pax6 was expressed in the dorsal
telencephalon, dorsal diencephalon (which includes pro-
someres P1–P3), and optic cup (Fig. 1F). In Gli3 / brains,
Pax6 expression in the telencephalon was greatly reduced,
whereas expression in the P3 region of the diencephalon
(ventral thalamus) was obviously expanded (Fig. 1G, black
arrow and red arrows, respectively). No obvious difference
in Pax6 expression was observed in the P1 and P2 regions
(dorsal hypothalamus) (Figs. 1F and 1G). Similar to previous
reports, Emx1 expression in the dorsal telencephalon was
totally absent, while weak Emx2 expression remained in
the mutant brain (data not shown; Tole et al., 2000). Dlx2
localized in the ventral thalamus and ganglionic eminence
in wild type brains (Fig. 1H). Expression was notably ex-
panded in both the ventral thalamus, coinciding with the
expansion of Pax6 in this area (Figs. 1G and 1I, red arrows),
and the ganglionic eminence in Gli3/ mutants (Figs. 1H
and 1I, black arrow). Nkx2.1 was expressed in the gangli-
onic eminence and in the hypothalamus in the wild type
brain (Fig. 1J). Consistent with Dlx2 expression, Nkx2.1
expression in the mutant ganglionic eminence was ex-
panded dorsally (Fig. 1K, black arrow), whereas there was no
difference in the hypothalamus (Figs. 1J and 1K). Together,
these data reveal that, in addition to a reduced dorsal
telencephalon, both the ganglionic eminence and P3 region
of the diencephalon (ventral thalamus) were expanded dor-
sally in the Gli3/ brain.
Shh is expressed in the basal plate of the telencephalon
and zona limitans intrathalamica (Zli) in the wild type
brain at 10.5 dpc (Fig. 1L). No expansion or ectopic Shh
expression was observed in the Gli3 mutant neural tube,
indicating that the reduced dorsal telencephalon and ex-
panded ganglionic eminence and dorsal hypothalamus are
not caused by an expanded ventral structure (Figs. 1L and
1M). These observations led us to examine Fgf8 expression
in the mutant brain, since FGF8 in the anterior neural ridge
is essential for the development of the ganglionic eminence
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and also for the repression of the dorsal telencephalon
(Crossley et al., 2001).
Fgf8 Is Up-Regulated in the Gli3/ Mutant Brain
In the developing wild type neural tube, Fgf8 is expressed
in the anterior neural ridge and isthmus (Figs. 2A, 2C, 2E,
2G, 2I, and 2K). Interestingly, Fgf8 was up-regulated in the
anterior neural ridge in Gli3/ embryos at 8.5 dpc (Figs. 2B
and 2D). The expansion of Fgf8 became more obvious at
later stages (Figs. 2F, 2H, 2J, and 2L). The increase in size of
the mutant ganglionic eminence, determined by Dlx2 and
Nkx2.1 in situ analysis (Figs. 2M and 2N and Figs. 1J and
1K), correlated with the up-regulation of Fgf8 expression,
suggesting that FGF8 might induce the expansion of the
ganglionic eminence (Figs. 2K–2N). Fgf8 expression was
also up-regulated in the isthmus (Figs. 2D, 2F, 2H, and 2J,
red arrows). Furthermore, we observed more tyrosine
hydroxylase-positive cells, presumptive dopaminergic neu-
rons, in the forebrain and around the isthmus in Gli3/
mutants (Figs. 2O and 2P). These neurons are induced by
the combination of FGF8 and SHH in the forebrain and
midbrain (Ye et al., 1998), suggesting that the up-regulation
of FGF8 can induce tyrosine hydroxylase-positive neuron
differentiation in Gli3/ mutants. We next analyzed En2
expression to determine whether the boundary of the mu-
tant isthmus was indeed expanded. Consistent with Fgf8
expression, En2 was also slightly expanded in the isthmus
of the Gli3/ brain (Figs. 2Q and 2R, yellow arrows). Thus,
in addition to an expanded anterior neural ridge, we also
found expansion of the isthmus in the Gli3/ brain.
Using the expression patterns of Pax6 and En2, we
compared the relative size of each brain segment between
wild type and Gli3/ mutants (Fig. 2S). From this analysis,
we found that the P3 region of the diencephalon (ventral
thalamus), posterior midbrain, and anterior hindbrain was
significantly expanded, while the dorsal telencephalon and
anterior midbrain were reduced in size (Fig. 2S). These
results indicate that not only dorsal–ventral patterning but
also anterior–posterior patterning of the brain is affected in
Gli3/ embryos. Since FGF8 is essential for patterning the
anterior neural ridge and isthmus, FGF8 up-regulation may
be responsible for the alterations of these areas in the
Gli3/ brain.
Gli3 Is Required to Limit Optic Stalk Identity
We next examined how eye development is affected in
Gli3/ mutants, since Gli3 is also expressed in the stalk
region of the optic field (Figs. 3A and 3B). Interestingly,
Pax6 expression in the optic cup was greatly reduced in
Gli3/ mutants, whereas Pax2 expression in the stalk was
up-regulated (Figs. 3C–3F). The mutant optic stalk also
became thicker than the wild type (Figs. 3E and 3F).
Consistently, Otx2 expression in the ventral half of the
optic cup was reduced, whereas Vax1 and Vax2 expression
in the optic stalk was expanded in the mutants (data not
shown). This marker gene analysis indicates that more
stalk cells and fewer optic cup cells comprise the optic field
in Gli3/ mutants, suggesting that GLI3 is needed to
repress stalk identity in the optic field (Figs. 3G and 3H).
Interestingly, we also observed an expansion of Fgf8 expres-
sion in the optic stalk (Figs. 3I and 3J). It is possible that the
expansion of the FGF8 domain impinges on the develop-
ment of the optic cup.
Fgf8 Expression Is Up-Regulated in the Gli3/
Mutant Face
Since we observed expanded Fgf8 domains in all regions
of the mutant neural tube, we hypothesized that Fgf8
expression in other tissues may also be up-regulated to
contribute to the malformations of Gli3/ mutants. Fgf8
expression in the facial primordia is important to maintain
proliferation of mesenchymal cells (Figs. 4A and 4C)
(Trumpp et al., 1999). In Gli3/ embryos, Fgf8 expression
was expanded in the facial primordia (Figs. 4B and 4D). We
characterized the facial phenotype by analyzing Pax9, Pax7,
and Dlx2 expressions at 10.5 dpc. Pax9 expression in the
medial nasal process was obviously expanded in the mu-
tants (Figs. 4E and 4F), which is consistent with the hyper-
telorism phenotype of GCPS patients. On the contrary,
mesenchymal cells in the lateral nasal process marked by
Pax7 expression were reduced in the mutants (Figs. 4G and
4H). Dlx2 is normally expressed in areas of the maxillary
and mandibular processes (Fig. 4I). In Gli3/ mutants, Dlx2
delineated an expanded maxillary process, while the size of
the mandibular process was not affected (Figs. 4I and 4J).
Together, these data reveal an increase in mesenchymal cell
number in the medial nasal process and maxillary process
and a reduction in number in the lateral nasal process in
Gli3/ embryos. These data do not completely support a
role for FGF8 in the expansion of facial domains, since the
lateral nasal process is smaller in Gli3/ mutants despite
the up-regulation of Fgf8 in this area. The mechanisms
underlying this phenomenon require further investigation.
Fgf8 Is Up-Regulated in the Gli3/ Mutant AER
Consistent with the brain, eye, and face, we also found
that Fgf8 expression in the apical ectodermal ridge (AER) of
limb buds is up-regulated, by approximately twofold (Figs.
4K–4O). Many mice with mutations that result in the
up-regulation of Fgf8 in the AER show a syndactyly pheno-
type caused by the reduction of apoptosis in the interdigital
regions (Jiang et al., 1998). We therefore examined whether
a decrease in apoptosis in Gli3/ mutants may also under-
lie their syndactyly phenotype. Because we found that most
Fgf8-expressing areas of the mouse embryo were abnor-
mally expanded in Gli3/ mutants, we evaluated both cell
proliferation and apoptosis in these areas to ascertain the
means by which these cell populations increased.
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Apoptosis Is Reduced in Gli3/ Mutants
By BrdU labeling, we did not see any difference in cell
proliferation between Gli3/ mutants and wild type em-
bryos in any areas (data not shown). Therefore, we exam-
ined cell death by TUNEL analysis. In the wild type mouse,
many TUNEL-positive cells were detected in the anterior
neural ridge, roof plate of the telencephalon, isthmus, facial
primordia, and limb buds (Figs. 5A, 5C, 5E, and 5G).
Interestingly, there was a consistent reduction of TUNEL-
positive cells in Gli3/ mutants (Figs. 5B, 5D, 5F, and 5H).
In the mutant neural tube, apoptosis was reduced in the
isthmus (Fig. 5B), anterior neural ridge, and roof plate (Fig.
5D), where we observed increased Fgf8 expression, suggest-
ing that the total number of the Fgf8-expressing cells is
normally restricted by cell death.
Consistently, reduction of apoptosis was also detected in
mutant limb buds at 9.5 and 11.5 dpc. In the wild type limb,
we observed a mass of apoptosis in the AER and anterior
necrotic area (Figs. 5E and 5G). In the Gli3/ mutant limb,
apoptosis in the AER was slightly reduced at 9.5 dpc (Fig.
5F). At 11.5 dpc, apoptosis was present in the AER similar
to wild type, but there was no detectable apoptosis in the
anterior necrotic area (Fig. 5H, black arrowheads). These
data suggest that GLI3 is normally involved in the induc-
tion or maintenance of developmental cell death to limit
the number of cells expressing Fgf8.
GLI3 Represses Fgf8 Expression Independently of
SHH Signaling
The up-regulation of the Fgf8 expression in the anterior
neural ridge, isthmus, eye, facial primordia, and AER in
Gli3/ mutants (Figs. 6E, 6J, and 6Y) suggests that GLI3
normally functions to repress Fgf8. The balance between
the activities of GLI3 and SHH may regulate Fgf8 expres-
sion. To test this idea, we compared Fgf8 expression pat-
terns between Gli3/, Shh/, and Gli3/;Shh/ mutant
embryos at 10.5 dpc. This approach is similar to Litingtung
and Chiang (2000), in which they elucidated that GLI3 is a
major repressor of motorneuron, V1, and V2 interneuron
development. In our case, if GLI3 were a repressor of Fgf8,
we would expect any loss of Fgf8 in Shh/ mutant mice to
be rescued by the additional Gli3 null mutation of Gli3/;
Shh/ mice. First, we checked Fgf8 expression in Shh/
embryos. Shh/ embryos showed severe holoprocen-
cephaly, and Fgf8 levels were notably reduced in the ante-
rior neural ridge, isthmus, and AER, while expression in the
facial primordia was not affected (Figs. 6B, 6G, and 6V).
Interestingly, in Gli3/;Shh/ double mutants, Fgf8 was
up-regulated in the neural tube, facial primordia, and AER,
similar to levels in Gli3/ mutants (Figs. 6D, 6E, 6I, 6J, 6X,
and 6Y). These observations suggest that SHH is not re-
quired for either the activation or maintenance of Fgf8
when GLI3 is also absent. Thus, GLI3 indeed functions as a
repressor of Fgf8 expression independently of SHH signal-
ing. The rescue of Fgf8 levels by the addition of a Gli3 null
mutation in the Shh/ background occurs in a gene dose-
dependent manner. We found slightly more Fgf8 expression
in the anterior neural ridge, isthmus, and AER of Gli3/;
Shh/ embryos compared with those in Shh/ mutants
(Figs. 6C, 6H, and 6W).
GLI3 is expressed in the dorsal half of the telencephalon
(Fig. 6K). Interestingly, Gli3 expression was obviously ex-
FIG. 3. Gli3/ mutant mice have expanded optic stalk and
reduced optic cup regions. (A, B) Gli3 is expressed in the optic stalk
(A, frontal view; B, lateral view) at 10.5 dpc. (C–F) Expression of the
optic cup marker Pax6 (C, D) and the optic stalk marker Pax2 (E, F).
(D) Expression of Pax6 is reduced in the Gli3/ mutant, whereas
Pax2 is expanded into the optic cup region in Gli3/ embryos (F).
(G, H) Schematic illustrations of the boundary between the optic
stalk (red) and the optic cup (blue) in wild type (G) and Gli3/
mutant (H) embryos. (I) Fgf8 is expressed in optic stalk at 10.5 dpc,
and expression is expanded in the Gli3/ mutant (J). Scale bars, 1
mm.
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panded toward the ventral side of the telencephalon in
Shh/ mutants (Figs. 6L and 6M). Consistently, Pax6
expression marking the dorsal telencephalon was also
shifted to the ventral side in Shh/ mutants (Fig. 6Q),
indicating that the brain is highly dorsalized. This expanded
dorsal phenotype was rescued by the superimposed Gli3
null mutation of Gli3/;Shh/ mice (Figs. 6R–6T), indicat-
ing that GLI3 normally has a dorsalizing role in wild type
neural development.
As we have described, reduced apoptosis is observed in
Gli3/ mutants, while excessive cell death is observed in
Shh/ mutants (data not shown; Ohkubo et al., 2002). It
FIG. 4. Expansion of Fgf8 gene expression in the face and limb bud in Gli3/ mutants. Expression of Fgf8 mRNA in wild type (A, C) and
Gli3/ mutants (B, D) viewed from lateral view (A, B) and frontal view (C, D) at 10.5 dpc. Fgf8 is expressed in the epithelium of the facial
primordium. (B, D) Fgf8 expression in all facial primordia is expanded. (E and F, frontal view) Pax9 is expressed in the medial nasal process
(MNP), which is expanded in the mutant face (F). (G and H, lateral view) Pax7 is expressed in lateral nasal process (LNP), which is reduced
in the mutant face (H). (I and J, lateral view) Dlx2 is detected in the maxillary and mandibular processes (Mx, Md), which are expanded in
the mutant face. Fgf8 mRNA distribution in the AER of wild type (K, M) and Gli3/ (L, N) limb bud at 10.5 dpc. (M, N) Transverse section
at yellow line of (K) and (L). (O) The number of Fgf8-positive cells in the AER of Gli3/ embryos is significantly increased (*, P  0.05)
compared with wild type embryos. 2nd, second pharyngeal arch; H, heart primordium. Scale bars, 2 mm in (A–J); 0.5 mm in (K, L); 0.1 mm
in (M, N).
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has been postulated that the excessive cell death in Shh/
mutants may result from the activation of BMP signaling
(Ohkubo et al., 2002). One mechanism by which BMP
signaling can be activated is by a reduction of GREMLIN,
an antagonist of BMP signaling, so we performed in situ
hybridization to compare Gremlin mRNA localization and
intensity between wild type and Gli3/ mutant mice. In
the wild type, Gremlin localized to the posterior half of the
limb buds, the juncture of the maxillary and mandibular
processes, and in somites (data not shown). A difference in
Gremlin expression was detected in the Gli3/ limb bud,
where it was expressed in the entire progress zone (Figs. 6e
and 6i). Figs. 6U–6i show the relationship between Shh,
Gli3, Fgf8, and Gremlin in the developing limb bud. In
Shh/ mutants, Gremlin expression was completely absent
in the limb bud (Fig. 6f), which may permit an increase in
apoptosis via BMP signaling and thus decrease the number
of Fgf8-expressing cells (Fig. 6V). In the double mutant
(Gli3/;Shh/), Gremlin is detectable throughout the en-
tire progress zone, indicating that GLI3 is normally an
important repressor of Gremlin expression (Fig. 6h). This
idea is further supported by the localization of Gli3 itself in
the limb bud of each mouse. Compared with the wild type
limb, where Gli3 expression is restricted to the anterior
portion (Fig. 6Z), in Shh/ mice, Gli3 is expressed through-
out (Fig. 6a) and could thus inhibit Gremlin transcription in
the posterior area as well. The lack of Gli3 in the Gli3/
mutant limb bud (Figs. 6b–6d), conversely allows more
Gremlin to be transcribed. The up-regulation of Gremlin
could then inhibit apoptosis by decreasing BMP signaling,
resulting in the increase in Fgf8-expressing cells in the AER
(Figs. 6W–6Y). The lower level of Gremlin expression in
Gli3/;Shh/ double mutants compared with Gli3/ mu-
tants (Figs. 6h and 6i) suggests that SHH may normally be
involved in the transcriptional activation of Gremlin.
DISCUSSION
In this study, we provide evidence that GLI3 is involved
in the suppression of Fgf8 in the developing mouse embryo.
The up-regulation of Fgf8 expression in Gli3/ mutants
may be sufficient to explain their developmental abnor-
malities, which can be extended to explain the abnormali-
ties of human GCPS. Since FGF8 is essential for the control
of pattern formation in many sites of the embryo, the
up-regulation of Fgf8 can affect the developmental pro-
grams of many tissues. Our results also suggest that GLI3
promotes developmental apoptosis in the anterior neural
ridge, isthmus, facial primordia, and AER. Herein, we
discuss the implications of these findings with references.
The Up-Regulation of Fgf8 and Gli3/ Neural
Abnormalities
In this study, we found expansion of the ganglionic
eminence, P3 region of the diencephalon (ventral thala-
mus), and isthmus in the Gli3/ mutant brain, and a
reduction of the dorsal telencephalon (Fig. 2S) (Johnson,
1967; Theil et al., 1999; Tole et al., 2000). The up-regulation
of FGF8 in the anterior neural ridge might explain the
expansion of the ganglionic eminence and reduction of
dorsal telencephalon in Gli3/ brain, since FGF8 is thought
to have dual activities in this region: one to induce the
ganglionic eminence and the other to suppress the character
FIG. 5. Reduction of apoptosis in the isthmus, anterior neural
ridge, and apical ectodermal ridge of Gli3/ mutants. Whole-
mount TUNEL analysis in wild type (A, C, E, G) and Gli3/
embryos (B, D, F, H). (A) Cell death in the isthmus is detected at 8.5
dpc (dorsal view). (B) There are fewer TdT-positive cells in the
isthmus of Gli3/ mutants (red arrows). (C, D) Cell death in the
anterior neural ridge (red arrowheads), dorsal midbrain region
(yellow arrowheads), and nasal epithelium (blue arrows) is detected
at 9.5 dpc, and is notably reduced in the mutant brain (frontal
views). (E, F) Cell death in the apical ectodermal ridge (AER) of the
limb bud is detected at 9.5 dpc in wild type embryos (lateral view).
In Gli3/ embryos, there are fewer TdT-positive cells (black
arrows). (G, H) At 11.5 dpc, TdT is detected in the anterior necrotic
area (black arrowheads) in addition to the AER. In Gli3/ embryos,
TdT is not detectable in the anterior necrotic area (black arrow-
heads), though there is no difference in the AER. Scale bars, 1 mm
in (A–H).
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FIG. 6. SHH is not involved in the regulation of Fgf8 expression by GLI3. (A–J) Expression of Fgf8 mRNA in the ANR (red arrowheads), isthmus
(red arrow), and face. Frontal (A–E) and lateral views (F–J) of 10.5-dpc embryos. In the ANR and isthmus of Shh/ mutants, Fgf8 is very weakly
expressed (B, G). Fgf8 expression is recovered in the ANR and isthmus of Gli3/;Shh/ (C, H) and Gli3/;Shh/ mutants (D, I). (K–O) Gli3
mRNA is detected in dorsal telencephalon and facial primordia of WT embryos (K, lateral view). In Shh/ and Gli3/;Shh/ mutants, Gli3
expression is expanded ventrally in the telencephalon (L, M). Black arrowheads indicate the ventral edge of Gli3 expression in the telencephalon.
Gli3 in the nasal process is also expanded in these mutants (black arrows). In Gli3/;Shh/ and Gli3/ embryos, Gli3 expression is not detected
(N, O). (P–T) Pax6 mRNA is detected in the dorsal telencephalon and diencephalon of wild type brains (P). Black arrow and red arrowhead show
the ganglionic eminence–cortex boundary and diencephalon–midbrain boundary, respectively. Red arrow shows the isthmus. (Q) Pax6 is
expressed more ventrally in Shh/ mutants. (R, S) The ganglionic eminence structure is recovered in Gli3/;Shh/ and Gli3/;Shh/ embryos.
(U–Y) Fgf8 expression in the AER, apical view. (V) In Shh/ mutants, Fgf8 is very weakly expressed. (W, X) The expression of Fgf8 is recovered
in Gli3/;Shh/ and Gli3/;Shh/ embryos. Note that the expansion of Fgf8 in the AER of Gli3/;Shh/ embryos (X) is similar to that in
Gli3/ embryos (Y). (Z) Gli3 mRNA is detected in the anterior portion of the limb bud. (a, b) Gli3 is expanded into the posterior portion in Shh/
and Gli3/;Shh/ embryos. (c, d) No Gli3 expression is detected in Gli3/;Shh/ and Gli3/ mutants. (e) Gremlin expression is detected in the
posterior portion of the wild type limb bud. (f) In Shh/ mutants, Gremlin is very weakly expressed. (g, h) Gremlin expression is recovered in
Gli3/;Shh/ and Gli3/;Shh/ double mutants, and is also detectable on the anterior side. (i) In Gli3/ mutants, expression of Gremlin is
strongly expanded into the anterior portion. Limb buds in (U–i) are forelimb buds with anterior (Ant.) at the top and posterior (Post.) at the bottom.
Scale bars, 1 mm in (A–T); 0.5 mm in (U–i).
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of the dorsal forebrain (Crossley et al., 2001). The enlarge-
ment of the ventral thalamus in Gli3/ mice might be
explained by a different mechanism, since Fgf8 is not
expressed in the ventral diencephalon, but this remains to
be determined. Bmps, Wnt1, Wnt3a, and Wnt8b are all
reduced in Gli3/ mutant brains (Tole et al., 2000, Theil et
al., 2002; data not shown), and are thus candidates for the
regulation of thalamus development. We know from our
data that GLI3 must normally suppress the development of
the ventral thalamus (through induction of BMPs or Wnts
perhaps), since in Gli3/;Shh/ double mutants the ventral
thalamus is able to develop, whereas in Shh/ single
mutants the ventral thalamus is completely missing (Figs.
6Q–6S).
The isthmus is also expanded in the Gli3/ mutant
brain. An expanded Fgf8 domain is likely responsible for the
expansion of the isthmus, since FGF8 is known to induce
the isthmus-restricted transcription factor En2 (Sato et al.,
2001). The expansion of the isthmus may cause the con-
comitant enlargement of the posterior midbrain and ante-
rior hindbrain, since both of these brain segments face the
isthmus and may thus receive heightened FGF8 signals.
Furthermore, tyrosine hydroxylase (TH)-positive cells,
which are induced by FGF8 and SHH (Ye et al., 1998), are
more numerous around the mutant forebrain and isthmus,
demonstrating greater FGF8 signaling in the forebrain and
peri-isthmus region in Gli3/ mutants.
In the developing eye, both Gli3 and Fgf8 are expressed in
the optic stalk. In Gli3/ embryos, the stalk is expanded,
while the optic cup is reduced (Fig. 3). It has been shown
that the administration of exogenous FGF8 can induce an
increase in optic stalk and reduction in optic cup identity if
it is applied prior to the invagination of the optic field
(Crossley et al., 2001). We found an up-regulation of Fgf8 in
the anterior neural ridge at 8.5 dpc, before invagination of
the optic field, suggesting that the increase in FGF8 results
in the expansion of the presumptive stalk region.
Abnormal Brain and Face Development in Gli3
Mutants
Similar to human GCPS patients, the medial nasal pro-
cess and maxillary process are enlarged in Gli3/ mutants,
whereas the lateral nasal process is reduced. An increase in
FGF8 cannot explain these changes, since Fgf8 expression
patterns do not completely correlate with these facial
changes (Fig. 4). It is possible that abnormal brain develop-
ment may instead be the cue for these facial malformations.
Mesenchymal cells in the facial primordia are derived from
the migration of cranial neural crest cells from particular
brain segments (Noden, 1983; Couly et al., 1998). Most of
the cells in the medial nasal process are derived from the
forebrain, whereas the lateral nasal process is derived from
the anterior midbrain. The cells in the maxillary process
originate in the posterior midbrain, while the mandibular
process is derived from both posterior midbrain and anterior
hindbrain. The abnormal proportions of the Gli3/ mutant
brain may thus affect the number of neural crest cells
migrating to the facial primordia: more cells from expanded
segments (diencephalon and posterior midbrain) to the
medial nasal process and maxillary process, and fewer cells
FIG. 7. GLI3 regulates cell death and the size of FGF8 domains. (A) In wild type embryos, SHH inhibits Gli3 gene expression in many sites.
Where GLI3 is present, it activates the expression of Bmps, which regulates cell death to alter the size of FGF8 domains. In the limb bud
only (blue lines), GLI3 also represses the BMP antagonist Gremlin. (B) In Shh/ embryos, GLI3 has more effect in up-regulating Bmp and
inhibiting Gremlin expressions, which leads to an increase in cell death. As a result, FGF8 domains are reduced. (C) In Gli3/;Shh/
embryos, Bmps are reduced and Gremlin is more widely expressed in the limb bud, contributing to a decrease in cell death and hence an
increase in number of FGF8-expressing cells. (D) In Gli3/ embryos, the outcome is similar to Gli3/;Shh/ embryos; a reduction of cell
death leads to the expansion of FGF8 domains. Therefore, the regulation of FGF8 domain size by Gli3 is independent of SHH function. The
blue pathway is only observed in limb buds.
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from the reduced segment (anterior midbrain) to the lateral
nasal process.
The Relationship between GLI3, BMP Signaling,
Apoptosis, and FGF8
Our investigations of Fgf8 expression in Gli3/ mice
revealed a ubiquitous up-regulation of Fgf8 in all areas
where developmental malformations are observed. How-
ever, we did not detect any difference in Fgf8 expression in
areas that are not affected in Gli3/ mice, namely the
hypothalamus, somites, and the pharyngeal endoderm. We
ascertained that there was a general increase in the number
of Fgf8-expressing cells in areas with expanded Fgf8 do-
mains. The question then was how the lack of Gli3 could
ultimately result in an increase in Fgf8-expressing cell
number. We investigated both cell proliferation and apopto-
sis to determine how Fgf8-expressing cells increased in
number in Gli3/ mutants and found a decrease in apopto-
sis in areas coinciding with expanded FGF8 domains.
The mechanism by which GLI3 can increase apoptosis is
not currently known, but our data and others support a role
for BMP signaling in this phenomenon, wherein BMP
signaling can increase apoptosis in some tissues. An endog-
enous inhibitor of BMP signaling, GREMLIN, has therefore
also been implicated in the regulation of apoptosis. Treat-
ment of chick limb buds with GREMLIN protein causes the
expansion of the AER, reduction of apoptosis, and enlarge-
ment of the limb bud without any obvious modifications of
Bmp expression (Merino et al., 1999). In Gli3/ mutant
limb buds, we found that Gremlin expression was ectopi-
cally expressed throughout the limb bud, whereas in the
wild type, it is restricted to the posterior side (Fig. 6). On the
contrary, no obvious difference in Bmps expression in the
Gli3/ mutant limb bud has been reported (Buscher et al.,
1997). In the wild type, therefore, GLI3 must inhibit Grem-
lin expression in the anterior limb bud, the only location
where GLI3 is expressed. In the Gli3/ mutant limb bud,
Gremlin is relieved from inhibition and expressed ubiqui-
tously, which may lead to a decrease in BMP-induced
apoptosis.
In Gli3/ mutant brains, Bmps expression has previously
been evaluated, and Bmp2, Bmp4, Bmp6, and Bmp7 are all
strikingly reduced by in situ hybridization analyses (Tole et
al., 2000). Local administration of exogenous BMP4 in the
forebrain at the neural plate stage increases cell death and
reduces both Fgf8 and Shh expressions (Furuta et al., 1997;
Ohkubo et al., 2002). Since we did not detect any obvious
reduction of BMP inhibitors in the Gli3/ brain (data not
shown), the reduction of cell death in the mutant brain may
result from reduced Bmp expression. Thus, the reduction of
BMP signaling in Gli3/ mutants, either by the increase in
Gremlin expression or by a decrease in Bmp expression,
may be pivotal in the reduction of apoptosis throughout the
mutant embryo.
The Role of SHH in the Regulation of Fgf8
Expression
We evaluated differences in Fgf8 levels in Shh/ mutants
compared with Gli3/ and Gli3/;Shh/ double mutants
at 10.5 dpc to determine whether SHH was playing a role in
Fgf8 regulation. In Shh/ mutants, Fgf8 expression was
reduced in all expression domains, suggesting that SHH is
required for Fgf8 expression. If SHH is required for the
development of the cells expressing Fgf8, we would ex-
pect no difference in Fgf8 expression in Shh/ single and
Gli3/;Shh/ double mutants. However, these double mu-
tants displayed an increase in Fgf8 expression, similar to
Gli3/ mutants, indicating that loss-of-function of Gli3
regulates Fgf8 expression independently of SHH signaling.
In the Shh/ mutant limb bud, Chiang et al. (2001) have
recently found that Fgf8 is present in early gestation, but as
the AER deteriorates so too does Fgf8 expression decrease.
Because Gli3 is ubiquitously expressed in the Shh/ limb
bud, GLI3 might be contributing to the deterioration of the
AER by increasing cell death. In support of this hypothesis,
the excessive apoptosis in Shh/ mutants disappears in
Gli3/;Shh/ double mutants (Litingtung and Chiang,
2000).
In this study, we found a marked increase in Gli3 expres-
sion in the Shh/ brain, face, and limb buds, suggesting
that SHH represses Gli3 transcription in the wild type. This
observation is consistent with their expression patterns,
which are segregated from each other. The repression of
Gli3 by SHH might limit Gli3 expression to the anterior
half of the limb bud, in the same way that it limits Gli3 to
the dorsal side of the neural tube (Figs. 1 and 6). Our data are
summarized in Fig. 7, in diagrams depicting the relation-
ship between SHH, GLI3, BMP signaling, apoptosis, and the
size of Fgf8 domains in the different backgrounds analyzed
in this study. In the wild type mouse (Fig. 7A), GLI3 may
positively regulate BMP-induced cell death by the activa-
tion of Bmp expression or the suppression of Gremlin
expression to limit the number of the cells expressing Fgf8.
Thus, the balance between cell proliferation and cell death
may be critical for the proper assignment of Fgf8-expressing
cells in the developing neural tube, face, and limb buds. In
Shh/ mutant embryos (Fig. 7B), Gli3 expression is ex-
panded, resulting in more cell death and hence reduced
FGF8 domains. The phenotype of Gli3/;Shh/ embryos is
quite similar to that of Gli3/ single mutants (Figs. 7C and
7D). Without GLI3, up-regulated Fgf8 expression is not
altered whether SHH is present or not, suggesting that SHH
is not directly involved in the regulation of Fgf8 expression
by GLI3.
Although we still have many unanswered questions, our
results suggest that GLI3 is essential for pattern formation
in the developing brain, face, and limb. GLI3 may deter-
mine the size of Fgf8-expressing domains by the modifica-
tion of cell death. Further analysis is required to determine
how GLI3 modulates cell death through BMP signaling or
other pathways.
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